The FREND™ COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab Cat. no F10 specimens directly from individuals suspected with COVID-19 by their healthcare provider. 01 Place a swab specimen into a lysis tube and stir well more than 10 times Close the lysis tube tightly with a filter dropper. Then, invert and gently squeeze the lysis tube Take 35 μL specimen and load onto the cartridge Insert the cartridge and get the result within 3 min Laboratory Information System Connectivity In the event of a pandemic, the management of a vast amount of clinical result is important. However, many laboratories face the challenge in arranging the essential information effectively(1). • Automatic Data Transfer & Collect Convenient Data Management Can help monitoring (serosurveillance) Reference (1) Division of Laboratory Systems (DLS), Clinical Laboratory COVID-19

Clinical Performance Evaluation The total of 109 clinical samples (34 positive and 75 negative) confirmed with RT-PCR were tested with the FREND™ COVID-19 Ag. It shows 94.12% PPA (Positive Percent Agreement) and 100.00% NPA (Negative Percent Agreement) as shown below. Ordering information FRENDTM System Lysis tubes Filter dropper with a specimen cup Disposable pipette tips or Disposable fixed volume pipettes Disposable sterile nasopharyngeal swab COVID-19 Ag Positive control swab COVID-19 Ag Negative control swab Nasopharyngeal swab Code chip Package insert Related products RT-PCR Kit Molecular...